ORIGINAL RESEARCH article

Front. Neurol.

Sec. Stroke

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1543101

Post 90-Day Outcomes of Acute Ischemic Stroke Patients Following Thrombectomy: Analysis of Real-World Data

Provisionally accepted
Adnan  Iqbal QureshiAdnan Iqbal Qureshi1,2William  I. BaskettWilliam I. Baskett3Ibrahim  A. BhattiIbrahim A. Bhatti1,4*Bruce  OvbiageleBruce Ovbiagele5Farhan  SiddiqFarhan Siddiq6Daniel  E. FordDaniel E. Ford7Camilo  R. GomezCamilo R. Gomez3Daniel  HanleyDaniel Hanley7Chi-Ren  ShyuChi-Ren Shyu3
  • 1Zeenat Qureshi Stroke Institutes, St. Cloud, Minnesota, United States
  • 2Department of Neurology, University of Missouri, Columbia, Kentucky, United States
  • 3University of Missouri, Columbia, Kentucky, United States
  • 4University of Missouri System, Columbia, Missouri, United States
  • 5Department of Neurology, University of California, San Francisco, San Francisco, California, United States
  • 6Department of Neurosurgery, University of Missouri, Columbia, Kentucky, United States
  • 7Johns Hopkins University, Baltimore, Maryland, United States

The final, formatted version of the article will be published soon.

Background: Previous studies have focused on 90-day outcomes in acute ischemic stroke patients who undergo thrombectomy, although long-term outcomes are not well understood. We compared the long-term rates of survival and new stroke recurrence among acute ischemic stroke patients who did and did not undergo thrombectomy.Using the Oracle Real World data (a de-identified large data source of multicenter electronic health records covering the period of January 2016 to January 2023), we analyzed 3,934 acute ischemic stroke patients who underwent thrombectomy and 3,934 propensity-matched controls of acute ischemic stroke patients who did not undergo thrombectomy. The risk of death or palliative care and new stroke following >90 days post-admission was ascertained using Cox proportional hazards regression analysis to adjust for potential confounders. We also estimated the rate of new stroke and palliative care-free survival using Kaplan Meier survival analysis.Results: Among 3,934 acute ischemic stroke patients who underwent thrombectomy, 2,660 patients either died or received palliative care or developed new stroke (median follow-up period of 775 days post initial stroke admission; interquartile range Q1=356 days, Q3=1341 days). The 2-year new stroke and palliative care-free survivals were 36.6% and 45.8% among patients who did and did not undergo thrombectomy, respectively (adjusted hazard ratio [HR], 1.19, 95% confidence interval [CI], 1.12-1.26). The risk of palliative care or death was not different (adjusted HR, 0.89, 95% CI, 0.77-1.02) between both groups, but the risk of new stroke was higher among patients who underwent thrombectomy (adjusted HR, 1.25, 95% CI, 1.18-1.33). The 2-year new stroke and palliative care-free survivals were 36.6% and 45.8% among patients who did versus those who did not undergo thrombectomy, respectively.Acute ischemic stroke patients who undergo thrombectomy are at greater risk of new stroke, palliative care, or death after 90 days, primarily driven by the occurrence of stroke.There is a need for closer surveillance and enhanced recurrent stroke prevention in this high-risk group.

Keywords: ischemic stroke, Thrombectomy, Long-term outcomes, Survival rates, Real-world data

Received: 10 Dec 2024; Accepted: 09 Apr 2025.

Copyright: © 2025 Qureshi, Baskett, Bhatti, Ovbiagele, Siddiq, Ford, Gomez, Hanley and Shyu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ibrahim A. Bhatti, University of Missouri System, Columbia, 65211, Missouri, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more